Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample

  title={Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample},
  author={Mohammad Hashemi and Sara Sanaei and Seyeh Mehdi Hashemi and E Eskandari and Gholamreza Bahari},
  journal={Clinical Breast Cancer},

Figures and Tables from this paper

Association of MDM4 Gene rs4245739 Polymorphism with the Risk and Clinical Characteristics of Colorectal Cancer in a Chinese Han Population
MDM4 gene rs4245739 polymorphism was connected to a less risk of CRC in females, non-drinkers,non-smokers, and people under 60 years old and was significantly linked with the survival of CRC.
MDM4 polymorphisms associated with the risk but not the prognosis of esophageal cancer in Cixian high-incidence region from northern China.
  • R. Zhou, Yan Li, X. Huo
  • Biology, Medicine
    Asia-Pacific journal of clinical oncology
  • 2022
AIM The mouse double minute 4 (MDM4) may contribute to tumorgenesis by inhibiting p53 tumor suppressor activity. This study was designed to investigate whether MDM4 polymorphisms could affect
Association of KLK3, VAMP8 and MDM4 Genetic Variants within microRNA Binding Sites with Prostate Cancer: Evidence from Serbian Population
Comparisons of genotype distributions among PCa and BPH patients, as well as between PCa patients and healthy controls, yielded no evidence of association between the analyzed genetic variants and the risk of developing PCa, but all three tested genetic variants have shown the association with the parameters of PCa progression.
Five MDM4 gene polymorphisms on cancer risk: An updated systematic review and meta-analysis
In the stratified analysis of rs1380576, it is found that Asians might have less susceptibility to cancer, and MDM4 rs4245739 polymorphism is inversely associated with cancer risk for Asians and breast cancer susceptibility.
Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer
The findings suggest that rs 937283 AG, rs937282 CG, rs1380576 CC, and rs4245739 AA genotypes were linked to hormonal receptor positive breast cancer and may be useful genetic markers for disease assessment.
The associations between MDM4 rs4245739 A>C polymorphism and cancer risk: a meta-analysis
These meta-analysis results suggest that MDM4 rs4245739 polymorphism was associated with a significantly decreased risk of cancer, especially in Asian populations, however, a trend of increased risk ofcancer was observed in ESCC.
The Relationship between Pre-miR-3131 3-bp Insertion/Deletion Polymorphism and Susceptibility and Clinicopathological Characteristics of Patients with Breast Cancer
The findings did not support a relationship between pre-miR-3131 3-bp ins/del polymorphism and the risk of BC, while, this variant was significantly related to late onset BC.
Association between CASP3 polymorphisms and overall cancer risk: A meta‐analysis of case‐control studies
The findings of this meta‐analysis support an association between CASP3 polymorphisms and cancer risk and larger and well‐designed studies are desired to evaluate these associations in detail.


Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility.
Considering the lack of association between MDM4 rs4245739 polymorphism and breast cancer, polymorphism of this gene seems to have no significant role in the pathophysiology of the disease.
Lack of Associations of the MDM4 rs4245739 Polymorphism with Risk of Thyroid Cancer among Iranian-Azeri Patients: a Case-Control Study
Considering the lack of any observed association between the MDM4 rs4245739 polymorphism and TC, it is concluded no significant role in the pathophysiology of the disease is concluded.
Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population
The findings showed that rs1406 C/A polymorphism increased the risk of BC in codominant (OR 1.60, 95 % CI 1.22–2.56, p = 0.012 CA + AA vs CC) inheritance models, indicating that CCNE1 rs 1406 polymorphism may contribute to BC risk.
MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects
The pooled results revealed that the MDM4 rs4245739C allele is associated with a decreased cancer risk in the heterozygous (AC vs. AA): ORs and 95% confidence intervals were used and the association was more prominent in Asians and population-based studies.
Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility
A combinational effect between MDM4 rs4245739 and P53 Arg72Pro variants in attenuating breast cancer risk is observed, highlighting the importance of the P53 tumor suppressor pathway genes during malignant transformation and supporting the hypothesis that genetic variants interrupting miRNA-mediated gene regulation might be important genetic modifiers of breast cancerrisk.
MDM4 genetic variants and risk of gastric cancer in an eastern chinese population
The results suggest that the MDM4 rs1380576 G variant may be markers for GCa susceptibility, and larger, independent studies are warranted to validate the findings.
The Role of MDM4 SNP34091 A>C Polymorphism in Cancer: A Meta-Analysis on 19,328 Patients and 51,058 Controls
The results of the meta-analysis showed that the MDM4 SNP34091 A>C polymorphism may function as a protective factor against cancer risk and showed a significant association in Chinese populations.
Association of a Genetic Variation in a miR-191 Binding Site in MDM4 with Risk of Esophageal Squamous Cell Carcinoma
The results elucidate that the MDM4 rs4245739 polymorphism contributes to susceptibility of ESCC and support the hypothesis that genetic variants, interrupting miRNA-mediated gene regulation, may modify cancer risk.
A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer
The data illuminate that the MDM4rs4245739SNP contributes to SCLC risk and support the notion that gene 3’-UTR genetic variants, impacting miRNA-binding, might modify SclC susceptibility.
Association Between Vascular Endothelial Growth Factor Gene Polymorphisms with Breast Cancer Risk in an Iranian Population
It is proposed that VEGF rs699947 polymorphism may increase the risk of BC development, and studies with larger sample sizes and different ethnicities are necessary to confirm the findings.